Clinical Trial Update: Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection [Phase 4]

View source ↗

Summary

Phase 4 trial update on tolerability and immunogenicity of Fluval AB Suspension for Injection in influenza prophylaxis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Prophylaxis

Drugs mentioned

• Fluval AB Suspension for Injection (Fluval AB Suspension for Injection)

Snippet

Sponsor: Fluart Innovative Vaccine Ltd, Hungary | Conditions: Influenza Prophylaxis | Phase 4 | Status: COMPLETED | Results posted: 2021-04-05